Skip to main content
Microbial Genomics logoLink to Microbial Genomics
. 2023 Dec 20;9(12):001159. doi: 10.1099/mgen.0.001159

Characterization of the RofA regulon in the pandemic M1global and emergent M1UK lineages of Streptococcus pyogenes

Xiangyun Zhi 1,2, Ana Vieira 1,2,3, Kristin K Huse 1,2, Paulo J Martel 4, Ludmila Lobkowicz 1, Ho Kwong Li 1,2, Nick Croucher 5, Ivan Andrew 6, Laurence Game 6, Shiranee Sriskandan 1,2,3,*
PMCID: PMC10763501  PMID: 38117674

Abstract

The standalone regulator RofA is a positive regulator of the pilus locus in Streptococcus pyogenes . Found in only certain emm genotypes, RofA has been reported to regulate other virulence factors, although its role in the globally dominant emm1 S. pyogenes is unclear. Given the recent emergence of a new emm1 (M1UK) toxigenic lineage that is distinguished by three non-synonymous SNPs in rofA, we characterized the rofA regulon in six emm1 strains that are representative of the two contemporary major emm1 lineages (M1global and M1UK) using RNAseq analysis, and then determined the specific role of the M1UK-specific rofA SNPs. Deletion of rofA in three M1global strains led to altered expression of 14 genes, including six non-pilus locus genes. In M1UK strains, deletion of rofA led to altered expression of 16 genes, including nine genes that were unique to M1UK. Only the pilus locus genes were common to the RofA regulons of both lineages, while transcriptomic changes varied between strains even within the same lineage. Although introduction of the three SNPs into rofA did not impact gene expression in an M1global strain, reversal of three SNPs in an M1UK strain led to an unexpected number of transcriptomic changes that in part recapitulated transcriptomic changes seen when deleting RofA in the same strain. Computational analysis predicted that interactions with a key histidine residue in the PRD domain of RofA would differ between M1UK and M1global. RofA is a positive regulator of the pilus locus in all emm1 strains but effects on other genes are strain- and lineage-specific, with no clear, common DNA binding motif. The SNPs in rofA that characterize M1UK may impact regulation of RofA; whether they alter phosphorylation of the RofA PRD domain requires further investigation.

Keywords: transcriptomics, mga, standalone regulator, streptococcal pyrogenic exotoxin A, scarlet fever, Group A Streptococcus

Data Summary

All analysed data are included in the supplementary Excel tables. Illumina RNA sequencing data have been submitted to the European Nucleotide Archive (ENA, www.ebi.ac.uk/ena) project PRJEB62819 with the accession numbers given in Table S1, available in the online version of this article.

Impact Statement.

RofA belongs to the group of ‘mga-like’ bacterial regulatory proteins that comprise a DNA binding domain as well as a phosphorylation domain (PRD) that is responsive to changes in sugar availability. In certain emm genotypes of Streptococcus pyogenes , rofA sits upstream of the pilus locus, to act as a positive regulator. The recent emergence of an SpeA exotoxin-producing sublineage of emm1 S. pyogenes (M1UK) has focused attention on the role of RofA; M1UK and its associated sublineages are characterized by three non-synonymous SNPs in rofA that include adjacent SNPs in the PRD. Here, we determine the impact of rofA deletion and the three rofA SNPs in both the widely disseminated M1global clone and the newly emergent M1UK clone. While production of SpeA undoubtedly contributes to infection pathogenesis, the evolution of M1UK points to a role for metabolic regulatory rewiring in success of this lineage.

Introduction

Resurgence of scarlet fever and invasive Streptococcus pyogenes infection in England has been associated with a sub-lineage (M1UK) of the pandemic M1T1 clone, which is distinguished from other prevalent emm1 strains by just 27 SNPs in the core genome, and increased expression of the phage-encoded superantigen SpeA [1]. Enhanced fitness of M1UK is inferred from its expansion within the population of S. pyogenes in England, being detected first in 2010 to becoming dominant by 2015–2016.

Among the 27 M1UK lineage-defining SNPs, three nonsynonymous mutations were identified in the gene rofA encoding the standalone transcriptional regulator RofA, a member of the RALP (RofA-like proteins) transcription regulator family [2]. The SNPs in RofA were also found in the two intermediate emm1 sublineages M113SNP and M123SNP that accompanied emergence of M1UK; M113SNP was detected as early as 2005, but did not make excess SpeA [3], consistent with a role for a SNP in the leader sequence of ssrA that contributes to the SpeA phenotype, and that is absent in the M113SNP strains [4].

RofA and its homologue Nra regulate genes of the fibronectin-binding, collagen binding, T-antigen (FCT) region [5]. RofA was first described as a positive transcriptional regulator of the fibronectin binding protein (prtF) in emm6 S. pyogenes [6]. Reported to bind specific motifs in target promoter DNA, RofA autoregulated its own transcription and appeared to positively regulate the speB operon as well as the pilus locus [7]. However, RofA has also been reported to negatively regulate a number of other regulators or virulence factors in an emm type-specific manner, such as mga, sagA and speA. RofA negatively regulated speA in emm6 S. pyogenes [2], but this was not the case for emm2 S. pyogenes [2, 8].

Despite intense genomic interrogation of the emm1 lineage and increasing understanding of the genome-wide impact of two component regulators such as covRS (csrRS), little is known about the role of RofA in the emm1 lineage. Unlike other genotypes, prtF is absent in emm1 strains, which have a type 2 FCT region, wherein rofA is adjacent to the FCT region [9]. The purpose of this study was therefore to characterize the rofA regulon in emm1 S. pyogenes and determine the significance, if any, of the three SNPs in RofA detected in the new sub-lineage M1UK.

Methods

Bacterial strains and growth conditions

S. pyogenes strains were all non-invasive, clinical upper respiratory tract infection isolates that were collected in north-west London, UK, for the purpose of sequential genotyping and genome sequencing [1]. Isolates for RNA sequencing (RNAseq) were either in the M1global or in the M1UK lineage, excluding any intermediates; possessed a phage containing the speA gene; were wild-type for covRS; and had overall phage and superantigen content matching the reference emm1 sequence MGAS5005. Strains used in this study are listed in Table S1 and were previously used for transcriptome comparison of M1global and M1UK lineages [3].

Routinely, S. pyogenes were cultured on Columbia blood agar (CBA) (OXOID), Todd-Hewitt (TH) agar or in TH broth (OXOID) at 37 °C with 5 % CO2 for 16 h. Chemically defined medium (CDM) supplemented with different sugars (glucose or mannose) was also used for growth of S. pyogenes . Where appropriate, spectinomycin (50 µg ml−1) or kanamycin (400 µg ml−1) were added to the culture medium for S. pyogenes. Escherichia coli strains Top10 (Invitrogen) and DH5α were used for cloning and grown in Luria broth (LB) or on LB agar with kanamycin (50 µg ml−1) or spectinomycin (50 µg ml−1).

Whole blood bacterial survival assay

Whole heparinized human blood was used in Lancefield assays as previously described [10]. Briefly approximately 50 c.f.u. of S. pyogenes was inoculated into 300 µl whole blood and incubated at 37 °C, with rolling for 3 h; each strain was tested in three normal donor whole blood samples (with technical triplicates for each donor). Blood donors whose samples permitted at least 2-fold multiplication of S. pyogenes over the 3 h incubation period were included. Input and output colony-forming units were measured by plating and the multiplication factor was calculated. Whole heparinized human blood was from consenting normal donors from a subcollection of the Imperial Tissue Bank (ICHTB, approved by Wales REC reference 17/WA/0161).

Construction of rofA disruption mutant

A 491 bp fragment downstream of the rofA gene was amplified (forward primer: 5′-GGAATTCCTCTTACATAAGATTCATATC-3′, reverse primer: 5′-GGGGTACCCTCTTCCTACACTTAGAAAGC-3′) incorporating EcoRI and KpnI restriction sites into the 5′ and 3′ ends respectively, and cloned into the suicide vector pUCMUT. A 523 bp fragment upstream of the rofA gene was amplified (forward primer: ACGCGTCGACCGCCATGTCACCACATTGCG-3′, reverse primer: 5′-AACTGCAGGGGTTACCTGTGCCATAATC-3′) incorporating PstI and SalI restriction sites into the 5′ and 3′ ends respectively and cloned into the same plasmid. The final construct (pUCMUTrofAKO) was introduced into M1global strains (H1488, H1489 and H1499) and MIUK strains (H1491, H1496 and H1490) by electroporation and crossed into the chromosome by homologous recombination. Transformants were selected using kanamycin (400 µg ml−1). Successful disruption of the rofA gene and insertion of the kanamycin resistance cassette was confirmed by PCR, DNA sequencing and whole genome sequencing.

Complementation of rofA strains

The rofA coding sequence, including native promoter, was amplified from both M1global and M1UK S. pyogenes DNA (forward primer: 5′-GACGCATGCCTCCTCTCAATGTGACATC-3′, reverse primer: 5′-ACGGATCCGTGGTGACATGGCGCTTATGTT-3′) incorporating BamHI and SphI restriction sites to each end of the PCR products, and cloned into BamHI- and SphI-digested shuttle vector pDL278 resulting in plasmids pDLrofAM1 and pDLrofAM1UK, which were confirmed by Sanger sequencing. The resulting plasmids were introduced into M1globalrofAKO (H1561) and M1UKrofAKO (H1582) by electroporation and selection using spectinomycin. The successful introduction of plasmid was confirmed by PCR specific for pDL278 backbone (forward primer: 5′-CATTCAGGCTGCGCAACTG-3′, reverse primer: 5′-TCGAATTCACTGGCCGTCG-3′) in each of the resulting isogenic strains H1591 (M1globalrofAKO complemented) and H1592 (M1UKrofAKO complemented).

Construction of rofA three SNP mutant strains

To introduce the three SNPs in rofA typical of M1UK into M1global (H1488), a 597 bp fragment downstream of the rofA gene was amplified from M1UK (H1496) template DNA (forward primer: 5′-AACTGCAGAGCACATTAAGTCCGATTGCAG-3′, reverse primer: 5′-ACGCGTCGACCCACACCTTAACTTAATCCCGA-3′) incorporating PstI and SalI restriction sites, and cloned into the suicide vector pUCMUT. A 1548 bp fragment upstream of the rofA gene was then amplified (forward primer: 5′-GGGGTACCCTAAAGTCGCGCAATGTGGTG-3′, reverse primer: 5′-AGCGAATTCGTGTAGGAAGAGAGGTCCCT-3′), incorporating EcoRI and KpnI restriction sites, and cloned into the same plasmid, resulting in pUCMUT+rofA3snp. The construct was introduced into M1global (H1488) by electroporation and crossed into the chromosome by homologous recombination. Transformants were selected using kanamycin (400 µg ml−1). Successful allelic replacement and insertion of the kanamycin resistance cassette was confirmed by PCR, DNA sequencing and whole genome sequencing.

To fix the rofA three SNPs in M1UK (H1496), the process was repeated to create plasmid pUCMUTrofA3snpFIX however template DNA from M1global (H1488) was used. The construct was introduced into M1UK (H1496) by electroporation and crossed into the chromosome by homologous recombination. Transformants were selected using kanamycin (400 µg ml−1). Successful allelic replacement and insertion of the kanamycin resistance cassette was confirmed by PCR and DNA and whole genome sequencing.

Quantitative real-time PCR

The extraction of RNA was done as described previously [11]. S. pyogenes were grown in THY broth until late logarithmic growth phase. The bacterial cultures were treated with aqua-phenol and phenol/chloroform/isoamyl alcohol (Sigma), and then precipitated with 2-propanol, followed by DNase treatment with TurboDNAfree (Ambion). RNA was reverse transcribed into cDNA using Transcriptor reverse transcriptase kit (Roche Diagnostics). Quantitative real-time PCR (qRT-PCR) was carried out for Spy0107, Spy0109 and speA using a real-time PCR System (Thermo Fisher Scientific) [3] and expression data were normalized to that of the housekeeping gene proS using a standard curve method as described previously [12].

Transcriptome (RNAseq) analysis

S. pyogenes were grown in THY broth until late logarithmic growth phase. Three M1global vs three M1global RofAKO, three M1UK vs three M1UKRofAKO were grown in triplicate (Table S1), RNA was prepared as previously described [11], and the quality and quantity of total RNA was evaluated using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano Total RNA Kit. rRNA was depleted using a NEBNext rRNA Depletion Kit (Bacteria), and RNAseq next-generation sequencing (NGS) libraries were made using the NEBNext Ultra II Directional RNA Library Prep Kit for Illumina according to the manufacturer’s instructions, by the MRC Genomics Core Lab. A minimum of 10 million paired-end 100 bp reads were generated for each sample on HiSeq 2500 and NextSeq 2000 Illumina sequencers. Illumina sequencing data have been submitted to the European Nucleotide Archive (ENA, www.ebi.ac.uk/ena) project PRJEB62819 with the accession numbers given in Table S1. RNAseq data were analysed according to the followed pipeline. Read quality was accessed using FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/), filtered and trimmed using trimmomatic [12], and mapped against the MGAS5005 (CP000017) reference genome using bowtie2 [13], with the highest sensitivity options. The resulting alignments were converted to sorted BAM files using vcftools [14]. Initial visualizations of the sequencing mapping were performed using the Integrative Genomics Viewer (IGV) [15], including the confirmation of rofA disruptions, three SNPs insertions and emm1 lineages. The mapped RNAseq reads were then transformed into a fragment count per gene per sample using HT-seq [16] packages and featureCounts [17] and the main results were compared. Exploratory data analysis (principal component analysis and heatmap of sample-to-sample distances) of the RNAseq data was implemented and plotted using the DESeq2 package [18]. Differential expression analysis in each dataset was performed using three different R packages (DESeq2 [18], EdgeR [19] and limma (https://bioconductor.riken.jp/packages/3.0/bioc/html/limma.html)) with a log2fold change of 0.5 and P<0.01 and P adj<0.05. Only differentially expressed (DE) genes in two of the three software programs used were considered as DE genes and used in the following analysis. Prophage regions were predicted using phaster [20], and curated by visual assessment and blast alignment. Operon prediction was performed using SP119 annotation [21] and motifs analysis was performed using XTREME (https://meme-suite.org/meme/doc/xstreme.html). Correlation coefficients for RNAseq were determined by plotting the log2 value of the array on the x-axis to the log2 value of the qRT-PCR on the y-axis. Linear regression was used to determine the line of best fit, and the resulting R 2 value was calculated, which represented the fitness of the data.

Murine intranasal infection

FVB/n female mice 6–8 weeks old (Charles River) were briefly anaesthetized with isofluorane and challenged intranasally with 5×106 c.f.u. S. pyogenes , administered as 5 µl per nostril. Nasal shedding was longitudinally and noninvasively monitored daily for 7 days following intranasal challenge using a nose-pressing technique [22]. Briefly, murine noses were pressed gently onto a CBA plate (Oxoid) 10 times, every 24 h. The resulting exhaled moisture was spread over the plate and colonies were counted following incubation at 37 °C, with 5 % CO2, for 24 h. On day 7 mice were killed, and nasal tissues, spleen and liver were dissected and plated onto CBA to quantify nasal and systemic S. pyogenes burden. Isogenic strains were compared over 7 days. To detect airborne shedding of bacteria within cages of infected mice, CBA settle plates (four per cage) were placed face up on the upper rack of individually HEPA filtered cages for 4 h on days, 0, 1, 2 and 3 post-infection as previously reported [22]. Airborne dispersal of S. pyogenes was quantified, by counting beta haemolytic colonies following overnight incubation of plates at 37 °C, with 5 % CO2. Procedures were in accordance with a UK Home Office Licence and local ethical review board approvals.

Comparative model building and histidine location predictions

No homologues of Spy0106 rofA were found in Protein Data bank (PDB) sequences of known structure. Therefore, more sensitive methods for the detection of weak homologues were required. Two different approaches were used: an Hidden Markov Model (HMM)-based search using HH pred [23] and the threading server LOMETS (Zhang Lab) [24], both consistently leading to the identification of three PDB sequences (PDB codes 4R6I, 5WAY and 3SQN). The signature motifs identified in the three proteins were confirmed with an HMMER search [25]. Structural alignment and search of the three identified structures using the FATCAT flexible alignment server [26] confirmed their homology at the structural level, which suggests that any of them could be used as a template for model generation. 4R6I (AtxA protein, avirulence regulator from Bacillus anthracis ) was the chosen template, as it had the longest alignment coverage of the target and the highest significance for the detected motifs. Using this template, models for M1rofAKO and M1UKrofAKO were produced using the MODELLER software [27]. The MODELLER template–target (guide) alignment was generated with the HHPRED server, and 50 models were produced for each of the rofA variants, using the recommended MODELLER parameters for a thorough structure search and minimization (MODELLER Manual, v 10.1). The quality of the generated models was assessed with the Ga341 score [28], the QMEAN score [29] and the MOLPROBITY server [30]. Each set of 50 models was loaded and visualized in the molecular viewer software PyMOL (Schrodinger) to access structural variance and the potential impact of amino acid substitutions between variants.

Statistical analysis

All statistical analyses were performed with GraphPad Prism 5.0. Comparison of two datasets was carried out using an unpaired Student’s t-test and three or more data sets were analysed by Kruskal–Wallis tests followed by Dunn’s multiple comparison test or ANOVA and Bonferroni post-test depending on sample size. Survival data were analysed by a Mantel–Cox (log rank) test. A P-value of ≤0.05 was considered significant.

Results

Characterization of the RofA regulon in emm1 S. pyogenes

To systematically characterize the rofA regulon in emm1 S. pyogenes, where the FCT locus is structurally distinct from other genotypes [9, 31], and to determine the prevalence of strain-specific effects, rofA in-frame deletion mutants were constructed in three different emm1 strains, H1488, H1489 and H1499 (each of which belong to the globally disseminated emm1 clade designated M1global), yielding the isogenic strains M1H1488rofAKO, M1H1489rofAKO and M1H1499rofAKO.

RNAseq analysis of broth-cultured isogenic strains of S. pyogenes identified 14 genes that were differentially expressed by at least 1.5-fold in all three isogenic strain pairs. Of these, 11 genes (78.57 %) were downregulated in all three of the M1global RofA mutants, consistent with a predominant role for RofA as a positive regulator, while three genes (21.43 %) were upregulated (Table 1). As expected, transcription of genes associated with collagen binding and the pilus locus (Spy 0107–0114) was markedly downregulated. The effect of RofA mutation on Spy0107 and Spy0109 was confirmed in one panel of isogenic strains by qRT-PCR; mRNA transcripts were significantly reduced in the absence of RofA, and this was reversed by complementation (Fig. S1A and B). Spy1081 (PTS system, cellobiose-specific IIA component), Spy1281 (two-component response regulator) and Spy1453 (phage protein) were also downregulated in all three rofA mutants. Genes that were upregulated in all rofA mutants included Spy0212 (N-acetylmannosamine-6-phosphate 2-epimerase), Spy0213 (N-acetylneuraminate-binding protein) and scpA, the gene encoding C5a peptidase. RNAseq failed to show any impact of rofA deletion on speA transcription. To more rigorously establish that there was no effect of RofA on speA, we quantified the transcription of speA in M1H1488rofAKO using qRT-PCR but observed no difference in comparison with the parent strain H1488 (Fig. S2A).

Table 1.

Genes differentially regulated in all three M1globalrofAKO strains compared with isogenic parent M1global strains

Gene ID

Gene name

Description

H1488

H1489

H1499

log2fold change

P adj

log2fold change

P adj

log2fold change

P adj

Spy0106

rofA

Transcriptional regulator

−11.241

<0.001

−13.902

<0.001

−13.938

<0.001

Spy0107

na

−3.388

<0.001

−3.747

<0.001

−3.816

<0.001

Spy0108

na

Signal peptidase I

−3.348

<0.001

−3.510

<0.001

−3.952

<0.001

Spy0109

na

−3.288

<0.001

−3.514

<0.001

−3.983

<0.001

Spy0110

eftLSL

Putative exported protein

−3.478

<0.001

−3.399

<0.001

−4.363

<0.001

Spy0111

na

Hypothetical protein

−3.406

<0.001

−3.596

<0.001

−4.044

<0.001

Spy0113

na

Transposase

−2.674

<0.001

−2.463

0.001

−1.153

<0.001

Spy0114

na

Sortase

−2.248

<0.001

−1.710

<0.001

−0.612

0.002

Spy0212

na

N-Acetylmannosamine-6-phosphate 2-epimerase

0.723

0.002

1.855

0.001

1.417

<0.001

Spy0213

na

N-Acetylneuraminate-binding protein

0.812

0.002

1.936

0.026

1.506

<0.001

Spy1081

na

PTS system, cellobiose-specific IIA component

−0.755

0.019

−0.952

0.010

−1.270

<0.001

Spy1281

na

Two-component response regulator

−0.601

0.010

−0.579

0.031

−0.601

<0.001

Spy1453

na

Phage protein

−0.694

0.005

−0.676

0.033

−0.804

<0.001

Spy1715

scpA

C5A peptidase precursor

0.589

0.003

2.323

<0.001

0.510

0.010

na, Not applicable.

Mapping of transcripts used the MGAS5005 (CP000017) reference genome

The clear role of RofA in regulation of the pilus locus in the three different M1global strains concealed quite marked interindividual differences between strains in the genes regulated by rofA (Tables S2–S4). Indeed, the number of genes downregulated by rofA mutation ranged from 60 to 146, while the number of genes upregulated ranged from 95 to 264 when considering individual isogenic strain pairs. In some cases, genes that were downregulated in one strain were upregulated in another. Notably only one rofA mutant showed upregulation of speA transcription, a derivative of H1499, which showed a 1.99-fold increase in speA transcription.

There were, however, some notable similarities in the rofA regulon between pairs of M1global strains (Tables S5–S7). For example, when considering M1global strains H1489 and H1499 (Table S6), streptolysin O and nga were upregulated in the absence of functional rofA, as were the two phage-encoded DNAses, Spd3 and SdaD2. However, the magnitude of effect was much greater in H1489; there was a 5–6-fold increase in transcription of phage-encoded DNAses in the absence of rofA, and an 8-fold increase in slo transcription.

When considering M1global strains H1488 and H1499, we found that rofA mutation resulted in downregulation of the entire operon Spy1732-1736 comprising speB and genes concerned with its processing and export, as well as the adjacent gene encoding DNAseB. This amounted to a 9-fold reduction in speB in H1488 and a 3.2-fold reduction in speB in H1499. This effect of RofA on speB was not observed at all in the H1489 rofA mutant; indeed, in this strain rofA mutation led to a >2-fold increase in Spy1738 spd (DNaseB). This strain also demonstrated a convincing 3–4-fold upregulation of the entire SLS operon when rofA was mutated, alongside a 3–5-fold increase in genes that comprise the mga regulon including scpA, sic and emm. There was no obvious reason for the divergence between strains in the components of the rofA regulon; in particular, there were no obvious variants in known regulatory genes.

Impact of three SNP RofA mutations in M1global strains

There are three non-synonymous mutations in rofA that are characteristic of all of the recognized intermediate S. pyogenes emm1 sublineages that preceded or accompanied emergence of M1UK [3]. To determine if these SNPs (M318I, F319V, D491N), two of which result in adjacent amino acid changes, have a measurable impact on S. pyogenes gene regulation, we introduced the same three SNPs into M1global strain H1488 to generate GAS-M1H1488rofA3SNPs (strain designation H1666). RNAseq was then used to compare the transcriptome of the transformant H1666 and the parent strain when cultured in broth in identical conditions to those above. Intriguingly, no genes were found to be differentially regulated using a threshold of log2 1. Three genes were detected as DE with a log2 fold change of 0.5 (Spy0501; Spy1678; smeZ) but these did not overlap with transcripts affected by rofA deletion. Furthermore, there was no impact on pilus locus genes even when qRT-PCR was used (Fig. S1A and B).

Growth of the rofA mutant strains and those with the three SNPs introduced was evaluated in chemically defined medium with glucose or mannose as carbon sources, but differences identified between the rofA mutants and parent strains were minimal (Fig. S3A and B). We considered the possibility that deletion of rofA might impact growth of S. pyogenes in other more relevant media, but growth and survival of the three RofA mutant strains in whole human blood did not differ from the isogenic parent strains (Fig. S4).

As the main reservoir for S. pyogenes is the nasopharynx, we compared the ability of the panel of three isogenic rofA emm1 strains to cause experimental nasopharyngeal infection using an established mouse model. Detection of a difference in longevity of carriage of emm1 isogenic strains was challenging due to severity impacting group size over time despite the low inoculum volume. There was an apparent trend for mice infected with S. pyogenes carrying the rofA three SNPs (GAS-M1H1488rofA3SNPs) to cause more intense infection lasting up to 7 days (Fig. S5A–C).

Characterization of the rofA regulon in emergent S. pyogenes lineage M1UK

We considered the possibility that the function of rofA may differ between emm1 lineages, and therefore undertook rofA gene deletion in a panel of three M1UK strains (H1496, H1491 and H1490) to yield M1H1496rofAKO, M1H1491rofAKO and M1H1490rofAKO. RNAseq comparison of the three pairs of isogenic strains cultured in broth revealed that 16 genes were differentially regulated in all three pairs of M1UKrofAKO relative to the M1UK parent strains (Table 2). Of these, 15 genes (93.8 %) were positively regulated by RofA, including the FCT locus genes, bglA2 operon (cellobiose PTS transporter operon), Spy1732 (protein export protein prsA precursor) and Spy1736 (hypothetical protein). A single gene, glnQ.2, was negatively regulated. Genes that were specifically DE in all three M1UK strains (i.e. were not observed following rofA deletion in M1global strains) included epf, bglA2 operon, the prsA precursor and a hypothetical protein Spy1736.

Table 2.

Genes differentially regulated in all three M1UKrofAKO strains compared with parent M1uk strains

Gene ID*

Gene name

Description

H1496

H1491

H1490

log2fold change*

P adj

log2fold change*

P adj

log2fold change*

P adj

Spy0106

rofA

Transcriptional regulator

−9.693

<0.001

−12.762

<0.001

−14.182

<0.001

Spy0107

na

−3.391

<0.001

−4.834

<0.001

−4.065

<0.001

Spy0108

na

Signal peptidase I

−3.220

<0.001

−5.301

<0.001

−4.389

<0.001

Spy0109

na

−3.486

<0.001

−5.181

<0.001

−4.517

<0.001

Spy0110

eftLSL

Putative exported protein

−3.305

0.001

−5.348

<0.001

−4.144

<0.001

Spy0111

na

Hypothetical protein

−3.622

<0.001

−5.206

<0.001

−3.966

<0.001

Spy0113

na

Transposase

−2.405

<0.001

−1.771

0.002

−2.179

0.002

Spy0561

epf

Putative extracellular matrix binding protein

−0.851

0.002

−0.586

0.008

−1.038

0.010

Spy1077

glnQ.2

Glutamine transport ATP-binding protein

0.796

0.022

0.771

0.001

1.334

0.005

Spy1079

na

PTS system 2C cellobiose-specific IIC component

−1.572

<0.001

−0.789

0.001

−0.994

0.004

Spy1080

na

Hypothetical protein

−1.275

0.002

−0.712

0.010

−1.108

0.006

Spy1083

na

Transcription antiterminator 2C BglG family

−1.116

0.002

−0.589

0.002

−0.943

0.003

Spy1084

na

Outer surface protein

−1.099

<0.001

−0.821

0.003

−1.030

0.002

Spy1085

bglA.2

Beta-glucosidase

−1.218

0.014

−0.758

0.005

−0.996

0.004

Spy1732

na

Protein export protein prsA precursor

−1.518

0.025

−0.722

0.002

−0.789

0.003

Spy1736

na

Hypothetical protein

−2.023

0.004

−1.420

0.001

−0.688

0.028

*Differentially expressed genes that are specific to M1UK are in bold type.

na, Not applicable.

Considering the individual pairs of isogenic strains, rofA deletion led to downregulation of 73–124 genes in the three different M1UK strains, and upregulation of 46–174 genes (Tables S8–S10). Although there was much interindividual strain variation among the M1UK strains tested, there were again additional notable similarities in the rofA regulon between pairs of M1UK strains (Tables S11–S13). Two M1UK strains (H1496 and H1491, Table S11) showed 2–5-fold upregulation of streptolysin O expression and downregulation of speB and adjacent genes following rofA disruption, similar to results observed among M1global strains. RofA inactivation in the two M1UK strains H1496 and H1490 (Table S12) resulted in downregulation of two operons: the V-type sodium ATP synthase ntp operon, and the citrate lyase cit operon. Neither operon was downregulated among M1global strains. Interestingly, RofA inactivation in M1UK strain H1491 had an opposing effect on both the ntp operon and citrate lyase operon, both of which were upregulated in response to rofA mutation, along with upregulation of the pur operon (Spy0022-0034), again illustrating quite marked interindividual strain variation in the impact of rofA mutation even among strains that are seemingly phylogenetically related.

There was a substantial overlap in seven genes that were positively regulated by RofA in both M1global and M1UK lineages, all of which were part of the FCT locus operon. Gene expression differences were confirmed by qRT-PCR (Fig. S1). We conclude that these genes therefore represent the core RofA regulon in emm1 S. pyogenes (Table 3). Similar to earlier findings, there was no evidence that speA was regulated by RofA in the M1UK lineage, as confirmed by qRT-PCR (Fig. S2B). Taken together the results pointed to a diversified RofA regulon in M1UK strains. Analysis of promoter regions of genes regulated by RofA in at least two of the three strains of each lineage (M1UK and M1global) was performed and no common motif was identified, even when genes up- and downregulated were considered separately (Fig. S6).

Table 3.

RofA core regulon: genes differentially expressed in both M1globalrofAKO and M1UKrofAKO strains compared with parent M1global and M1UK strains

Gene ID

Gene name

Description

M1global

M1UK

H1488

H1489

H1499

H1496

H1491

H1490

log2fold change

P adj

log2fold change

P adj

log2fold change

P adj

log2fold change

P adj

log2fold change

P adj

log2fold change

P adj

Spy0106

rofA

Transcriptional regulator

-11.241

<0.001

−13.902

<0.001

−13.938

<0.001

−9.693

<0.001

−12.762

<0.001

−14.182

<0.001

Spy0107

na

−3.388

<0.001

−3.747

<0.001

−3.816

<0.001

−3.391

<0.001

−4.834

<0.001

−4.065

<0.001

Spy0108

na

Signal peptidase I

−3.348

<0.001

−3.510

<0.001

−3.952

<0.001

−3.220

<0.001

−5.301

<0.001

−4.389

<0.001

Spy0109

na

−3.288

<0.001

3.514

<0.001

−3.983

<0.001

−3.486

<0.001

−5.181

<0.001

−4.517

<0.001

Spy0110

eftLSL

Putative exported protein

−3.478

<0.001

−3.399

<0.001

−4.363

<0.001

−3.305

0.001

−5.348

<0.001

−4.144

<0.001

Spy0111

na

Hypothetical protein

−3.406

<0.001

−3.596

<0.001

−4.044

<0.001

−3.622

<0.001

−5.206

<0.001

−3.966

<0.001

Spy0113

na

Transposase

−2.674

<0.001

−2.463

0.001

−1.153

<0.001

−2.405

<0.001

−1.771

0.002

−2.179

0.002

Column headers provide parent (wild-type) strain; comparisons are with the cognate isogenic RofA deletion mutant. na, Not applicable.

Reversal of the RofA three SNPs in M1UK

As the RofA regulon in M1UK appeared distinct from M1global, it seemed possible that the three SNPs present in rofA in the M1UK lineage may be significant in this strain background, noting that the strain background is characterized by a number of additional SNPs that may alter strain physiology. We therefore evaluated the impact of ‘reversing’ the rofA three SNPs in M1UK strain H1496, to result in strain M1UKrofA3SNPsFixed (strain designation H1665). In contrast to our findings in M1global, where introduction of the three SNPs made little impact on the transcriptome, we found that 91 genes were differentially regulated in M1UKrofA3SNPsFixed. These genes included bacteriocin, epuA, eight phage genes and several hypothetical genes (Table S14). There was surprising overlap between the transcriptome of the RofA deletion mutant and the mutant with reversal of the three SNPs in the same strain background (Fig. 1), suggesting that the function of RofA, at least in this strain, was impaired by reversal of the three SNPs. Two genes (Spy1142-1143) were downregulated in both M1UKrofAKO and M1UKrofA3SNPs. Over 40 % (27/66) (Table 4) of the genes upregulated in the same M1UK rofA mutant were also upregulated when the three SNPs in rofA were ‘fixed’; these included three cytosolic proteins, two phage proteins, three large subunit (LSU) ribosomal proteins, epuA, as well as iojap protein family protein and nrdG. None of these genes were part of the core RofA regulon. The findings attribute a role for the three SNPs in RofA repressor activity in M1UK strains.

Fig. 1.

Fig. 1.

Venn diagram enumerating upregulated genes following disruption of rofA (blue circle, M1UKrofAKO left) and fixing of three SNPs (green circle, M1UK3SNPsfixed, right) in isogenic derivatives of M1UK strain H1496. Number of overlapping upregulated genes shown in centre. Representative genes assigned to each category are indicated in boxes.

Table 4.

Genes differentially expressed in both M1UKrofA3SNPsFixed and M1UKrofAKO compared with parent M1UK strain

Gene ID

Gene name

Description

M1UKrofA3SNPsFixed

M1UKrofAKO

log2fold change

P adj

log2fold change

P adj

Spy0073

na

Hypothetical protein

1.334

0.003

1.305

0.007

Spy0199

na

Deoxyuridine 5′-triphosphate nucleotidohydrolase

0.752

0.003

0.828

0.045

Spy0211

rpmH

LSU ribosomal protein L34P

1.483

0.015

1.669

0.003

Spy0265

na

iojap protein family

1.423

0.003

1.510

<0.001

Spy0269

na

Putative cytosolic protein

1.213

0.003

1.260

0.001

Spy0399

na

Putative membrane-associated protein

3.000

0.005

2.556

0.003

Spy0412

na

LSU ribosomal protein L33P

1.793

0.002

1.671

0.008

Spy0493

na

Putative cytosolic protein

1.494

0.002

1.154

0.011

Spy0585

epuA

epuA protein

1.392

0.003

1.176

0.002

Spy0635

rpmA

LSU ribosomal protein L27P

0.710

0.020

0.659

0.037

Spy0805

srtK

Nisin biosynthesis sensor protein

0.655

0.011

0.680

0.017

Spy0985

na

phnA protein

0.947

0.006

0.894

0.012

Spy1087

na

Putative cytosolic protein

1.889

0.005

2.208

<0.001

Spy1089

na

Hypothetical protein

2.783

0.001

2.150

0.005

Spy1192

rsuA

Phage protein

2.609

0.001

1.689

0.015

Spy1223

na

DNA-binding protein HU

1.011

0.004

0.991

0.015

Spy1239

na

Putative cytosolic protein

1.062

0.001

1.447

0.014

Spy1295

na

Putative cytosolic protein

0.814

0.016

1.084

0.015

Spy1433

na

Phage protein

1.361

0.004

1.286

0.007

Spy1476

na

ATP/GTP hydrolase

0.882

0.011

1.165

0.001

Spy1504

na

Putative membrane spanning protein

1.428

0.002

1.175

0.010

Spy1592

na

Ribosomal-protein-alanine acetyltransferase

0.612

0.032

0.691

0.015

Spy1611

rpoE

DNA-directed RNA polymerase delta chain

0.646

0.023

0.947

0.001

Spy1650

na

degV family protein

1.274

0.003

0.886

0.046

Spy1752

na

LSU ribosomal protein L33P

1.849

0.001

1.287

0.032

Spy1789

nrdG

Anaerobic ribonucleoside-triphosphate reductase activating protein

0.643

0.027

0.738

0.009

Spy1792

na

Hypothetical protein

1.293

0.003

1.368

0.008

na, Not applicable.

We considered the possibility that the activity of RofA may impact M1UK S. pyogenes growth but did not detect a significant difference when comparing growth of a panel of isogenic strains in CDM with glucose or mannose as carbon sources (Fig. S3C and D). We again compared the survival of three M1UK parent strains, with the three isogenic M1UK rofA mutant derivatives in whole human blood, but found no difference between the isogenic strains (Fig. S4). Finally, we were unable to detect a difference when comparing the strains in a murine model of nasopharyngeal carriage albeit that, again, group sizes were affected by infection severity (Fig. S7A–C).

Bioinformatic analysis of RofA and implications of the three SNPs

To predict if the location of the three nonsynonymous SNPs would have consequences for RofA regulatory function, bioinformatic analysis of the RofA amino acid sequence was carried out. Despite the low genetic similarity (and 19–20 % amino acid sequence identity), domain organization of RofA was remarkably similar to AtxA, a virulence regulator from Bacillus anthracis (4R6I); MgaSpn, an Mga regulator from Streptococcus pneumoniae (5WAY); and putative Mga family transcriptional regulator from Enterococcus faecalis (3SQN) as shown in Fig. 2. RofA contains two putative DNA binding domains: the helix–turn–helix mga domain (HTH_mga) (residues 7–65) and an mga DNA-binding domain (Mga) (76–156 residues), followed by a phosphotransferase system (PTS) regulation domain (PRD) of Mga located between residues 171 and 384 and a putative C-terminal PTS EIIB-like domain only identified by structural analysis. The two adjacent RofA amino acid changes in M1UK and related sublineages are in the PRD_mga domain (M318I and F319V) while the other amino acid change (D491N) is in the final section of a putative EIIB-like domain. In silico analysis suggests that, unlike other mga-like proteins, RofA may have just one longer fused functional PRD instead of two. PRD_mga domains are crucial for mga activation, through histidine phosphorylation events, in response to environmental sugar status, while EIIB-like domains may influence dimerization [32–35]. To determine if the three RofA SNPs in M1UK may have an impact on RofA histidine phosphorylation, 50 RofA model structures of each form were generated with the comparative modelling software MODELLER. Analysis highlighted a possible effect of the M318I substitution upon His278: the 50 superimposed M1global models revealed that, in at least three different conformations, Met318 and His278 residues are close enough to produce steric hindrance (Fig. 3), with a probable mode of interaction (His N to Met S) that is well described [36]. By contrast, no such interaction can occur in M1UK as Met318 is replaced by an isoleucine residue, with a side chain comprising only nonpolar carbon and hydrogen atoms (Fig. 3). Consequently, the distribution of His278–M318I distances are larger in the M1UK than in M1global models (Fig. S8), an effect that is further reinforced by the shorter length of the Ile chain in M1UK.

Fig. 2.

Fig. 2.

Schematic representation of RofA and mga homologous domain structures. Defined lines indicate domains that have been identified by their interpro signature. Blurred boundaries indicate domains predicted by structural similarity. Helix–turn–helix (HTH) and DNA-binding domains are represented in blue and red, phosphotransferase system regulatory domains (PRD) in green and putative EIIB domains in orange. From the top, the diagram depicts RofA; MgaSpn, an Mga regulator from Streptococcus pneumoniae (5WAY); AtxA, a virulence regulator from Bacillus anthracis (4R6I); and a putative Mga family transcriptional regulator from Enterococcus faecalis (3SQN). RofA amino acid changes in M1UK are indicated by red asterisks.

Fig. 3.

Fig. 3.

Conformations of His-278 and Met/Ile-318 in the 50 homology models of RofA in M1global lineage strains (upper panel) and M1UK lineage strains (lower panel). His-278 is represented in orange and Met/Ile318 residues in green. Interatomic distances between His278 and Met318 are represented by a line when they are below the van der Waals contact distance for the corresponding atoms. Allelic variants Phe/Val-319 shown in turquoise. More distant histidine residue His-380 is shown in yellow.

Discussion

In this study, we analysed the RofA regulon in six different emm1 strains that were representative of the two contemporary major emm1 lineages (M1global and M1UK). The transcriptome of RofA deletion mutants has not to our knowledge been fully reported; our results suggest that the transcriptomic changes may vary according to strain background, even within the same emm genotype. Although the pilus locus was a major target of RofA regulation in both lineages, RofA mutation led to a number of discrete transcriptomic changes that were unique to M1UK strains and were not seen in M1global. Although introduction of the three SNPs into rofA made little or no impact in an M1global strain, the reversal of three SNPs in an M1UK strain led to an unexpected number of transcriptomic changes that, in part, recapitulated transcriptomic changes seen when deleting RofA. Computational analysis identified a key role for target residues in RofA that may interact with histidine residues, predicting that phosphorylation of RofA and function of the PRD may differ in M1UK strains.

RofA was first identified as a positive regulator of the prtF genes in emm6 S. pyogenes [6]. Previous investigators have identified apparent serotype-specific differences in RofA target genes when evaluating emm2, emm6 and emm49 isogenic mutants; our data suggest that the range of target genes that are subject to RofA regulation may well vary from strain to strain despite sequence identity between promoters [2, 6, 37]. Based on our findings, the regulon of RofA cannot easily be explained by consensus DNA binding sequence motifs or involvement of other regulators. Indeed, the predicted motifs were quite different from previously published RofA motifs [38]. The sequence logos contained poly-AT tracts, which are known to be relatively flexible [39]. This suggests RofA may recognize DNA conformation or curvature, rather than a specific sequence, as proposed for the structurally similar AtxA protein [40]. This would explain how this single protein can have such a variable regulon across the species, and even between closely related isolates of the same emm type. Hence subtle changes to the protein’s structure, such as those caused by the three SNPs investigated in this study, may have an effect through differentially influencing RofA’s association with multiple loci, rather than simply changing its affinity for a clearly defined binding motif.

We have undertaken systematic analysis of the RofA regulon in the widely successful emm1 pandemic lineage (M1global). Although our findings confirm the role of RofA as a strong positive regulator of the pilus locus in emm1 strains as previously reported, we also identified a clear role for RofA in regulation of Spy0212/0213, Spy1081 (PTS system), Spy1281 (two-component regulator), phage protein (Spy1453) and scpA. RofA was reported to suppress transcription of speA, sagA and mga [2] but we could not confirm this in emm1 strains. In the current study, RNAseq identified speA as a target for repression in only one rofA mutant. Although single M1global and M1UK strains showed upregulation of sagA upon rofA deletion, other strains from each lineage showed downregulation of sagA, underlining the importance of considering more than one strain when examining regulatory gene control. When we compared the RofA regulon between M1UK and M1global we identified additional unique genes that were regulated in only M1UK including epf, glnQ.2, the bglA.2 operon, Spy1732 and Spy1736.

RNAseq data showed that two of the three M1UK rofA mutant strains exhibited downregulation of the ntpAB operon that encodes V-type ATPases. Interestingly our recently reported proteomic data showed that strains from M1UK and the M123SNP sublineage have reduced (rather than increased) levels of NtpA and B in the cytosol compared with strains from M1global and the M113snp sublineage [3]. The role of the V-type ATPase in the physiology and pathogenesis of S. pyogenes is not known though the operon may be regulated by small RNAs [41]. V-type ATPases, located in the plasma membrane, couple the transfer of protons or sodium cations across the membrane with ATP hydrolysis or synthesis, and are responsible for cytoplasmic proton extrusion, regulating internal pH [42]. S. pyogenes performs only lactic acid fermentation for production of energy and can survive despite lowering the pH to ∼5.4 in growth medium [41]. Thus, the V-type ATPase in S. pyogenes might be involved in pumping hydrogen ions from the bacterial cytosol to overcome acid stress to survive the acidic conditions inside the host lysosome.

RofA also appears to play a role in positive regulation of the citrate lyase operon which is also involved in pH tolerance, in some, but not all, emm1 strains. One M1global and two M1UK rofA mutant strains showed reduced transcription in the citABCDE operon. Citrate lyase is a key enzyme that allows the microorganism to enter the citric acid cycle in the reductive mode and the citrate lyase operon may help S. pyogenes adapt to metabolic stress, such as low pH, lactate accumulation and nutrient-deprived, hypoxic conditions [43–45]. This metabolic ‘switch’ facilitates survival during environmental transitions encountered in the infective process [45], while absence of the citrate lyase operon may render emm12 S . pyogenes strains less fit under nutrient-deprived conditions [43].

The reversal of the three SNPs in rofA in an M1UK strain resulted in a transcriptomic effect that in part emulated rofA deletion in the same strain. This suggests that the function of rofA in M1UK strains is somehow reliant on these three SNPs, while this is not the case in M1global strains, potentially because of the subsequent adaptive mutations that have occurred in M1UK. We noted upregulation of phage genes in the strain with reversal of the rofA three SNPs that was unexpected, and may reflect a stress response. Davies et al. recently reported the effects of reversal of the three 3SNPs in an M1UK strain, and found that no gene was differentially expressed by the repair of the rofA three SNPs [4]. In contrast, we found 91 genes to be differentially regulated in the rofA repaired strain (10 genes downregulated and 81 genes upregulated). While this could be a strain-specific effect, or related to the different growth media used, or related to different expression thresholds used in each study, the data cannot be compared directly as the two studies used different reference strains.

Currently, the mechanism by which RofA is controlled is unknown. Experimental data relating to Mga (the closest related protein studied) suggests that the PRD is activated by histidine phosphorylation events that lead to a defect in protein oligomerization, altered gene expression and, in some cases, virulence attenuation [32–35]. The number and positions of phosphorylated histidines within the PRD_mga domain vary among the regulators, and phosphorylation can positively or negatively affect protein activity [32]. Our protein model predictions show that the amino acid substitutions between M1global and M1UK may interfere with RofA histidine phosphorylation. In fact, M318I replacement could disrupt a stabilizing interaction between this residue and His278. This native interaction could bias the His conformation towards the proximal rotamer (when the His residue is nearest to M318), limiting access to its kinase enzyme and resulting in different phosphorylation activation events between lineages. Whether the PRD of RofA is indeed phosphorylated at His278 is currently unknown, as is the experimental impact of the three SNPs on phosphorylation of RofA.

Our study has highlighted the importance of examining multiple strains when considering the role of S. pyogenes regulators, but a limitation is the number of strains that can be practically examined in different growth conditions. This extends in particular to the testing of strains in vivo, where comparison of multiple isogenic strains, or different lineages, in the same model can be challenging and may require a prohibitive number of mice per group to demonstrate a clear difference. Indeed, the pleiotropic transcripts affected by RofA deletion may affect S. pyogenes survival phenotypes in opposing directions, such that the net effect of RofA deletion may not recapitulate the effects of deletion of pilus protein genes [5]. The acquisition of the three SNPs in rofA in the M1T1 S. pyogenes lineage is unique to the emm1 intermediate sublineages and M1UK; to date, we have not detected these three SNPs in any other emm genotype. As such, the SNPs act as a useful marker of the new lineages. The three SNPs in rofA were identified as early as 2005 [3] and have persisted throughout the evolution of M1UK, present in both M113SNP and M123SNP strains, underlining a key role in the success of the novel lineage.

Supplementary Data

Supplementary material 1
Supplementary material 2

Funding information

This work was funded by UKRI (MRC) grant MR/P022669/1.

Acknowledgements

The authors acknowledge the support of the NIHR Imperial Biomedical Research Centre and Colebrook Laboratory in collection and curation of clinical S. pyogenes throat isolates and the Imperial College Healthcare Trust Tissue bank for access to normal donor blood samples. They also thank the MRC LMS sequencing facility for undertaking RNA sequencing during the early stages of the COVID-19 pandemic and acknowledge support from UKHSA colleagues Drs Theresa Lamagni and Vicki Chalker in securing funding for work on M1UK. H.K.L. is an MRC CMBI Clinical Training Fellow and N.C. is a Sir Henry Dale Fellow, jointly funded by Wellcome and the Royal Society (grant no. 104169/Z/14 /A).

Author contributions

Conceptualisation, funding S.S.; Investigation X.Z., K.K.H., L.L., H.K.L., I.A.; Resources, supervision, L.G.; Data curation and analysis A.V., P.J.M., N.C.; Writing first draft X.Z., A.V., S.S.; Writing, Review and Editing, all authors.

Conflicts of interest

The authors declare that there are no conflicts of interests.

Ethical statement

All animal use was licensed by a UK Home Office Project Licence using protocols approved by the local ethical review process. Whole heparinized human blood was from consenting normal donors from a subcollection of the Imperial Tissue Bank (ICHTB, approved by Wales REC reference 17/WA/0161).

Footnotes

Abbreviations: DE, differentially expressed; FCT, fibronectin-binding, collagen binding, T-antigen; HTH, helix–turn–helix; LSU, large subunit; NGS, next-generation sequencing; PRD, PTS regulation domain; PTS, phosphotransferase system; qRT-PCR, quantitative real-time PCR; RNAseq, RNA sequencing.

Eight supplementary figures and 14 supplementary tables are available with the online version of this article.

References

  • 1.Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019;19:1209–1218. doi: 10.1016/S1473-3099(19)30446-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Beckert S, Kreikemeyer B, Podbielski A. Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect Immun. 2001;69:534–537. doi: 10.1128/IAI.69.1.534-537.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Li HK, Zhi X, Vieira A, Whitwell HJ, Schricker A, et al. Characterization of emergent toxigenic M1UK Streptococcus pyogenes and associated sublineages. Microb Genom. 2023;9 doi: 10.1099/mgen.0.000994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Davies MR, Keller N, Brouwer S, Jespersen MG, Cork AJ, et al. Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat Commun. 2023;14:1051. doi: 10.1038/s41467-023-36717-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Abbot EL, Smith WD, Siou GPS, Chiriboga C, Smith RJ, et al. Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin. Cell Microbiol. 2007;9:1822–1833. doi: 10.1111/j.1462-5822.2007.00918.x. [DOI] [PubMed] [Google Scholar]
  • 6.Fogg GC, Gibson CM, Caparon MG. The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenes . Mol Microbiol. 1994;11:671–684. doi: 10.1111/j.1365-2958.1994.tb00345.x. [DOI] [PubMed] [Google Scholar]
  • 7.Granok AB, Parsonage D, Ross RP, Caparon MG. The RofA binding site in Streptococcus pyogenes is utilized in multiple transcriptional pathways. J Bacteriol. 2000;182:1529–1540. doi: 10.1128/JB.182.6.1529-1540.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kreikemeyer B, McIver KS, Podbielski A. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol. 2003;11:224–232. doi: 10.1016/s0966-842x(03)00098-2. [DOI] [PubMed] [Google Scholar]
  • 9.Kratovac Z, Manoharan A, Luo F, Lizano S, Bessen DE. Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes . J Bacteriol. 2007;189:1299–1310. doi: 10.1128/JB.01301-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lynskey NN, Goulding D, Gierula M, Turner CE, Dougan G, et al. RocA truncation underpins hyper-encapsulation, carriage longevity and transmissibility of serotype M18 group A streptococci. PLoS Pathog. 2013;9:e1003842. doi: 10.1371/journal.ppat.1003842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Turner CE, Kurupati P, Jones MD, Edwards RJ, Sriskandan S. Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis. 2009;200:555–563. doi: 10.1086/603541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120. doi: 10.1093/bioinformatics/btu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Clausen PTLC, Aarestrup FM, Lund O. Rapid and precise alignment of raw reads against redundant databases with KMA. BMC Bioinformatics. 2018;19:307. doi: 10.1186/s12859-018-2336-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Danecek P, Auton A, Abecasis G, Albers CA, Banks E, et al. The variant call format and VCFtools. Bioinformatics. 2011;27:2156–2158. doi: 10.1093/bioinformatics/btr330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–26. doi: 10.1038/nbt.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Anders S, Pyl PT, Huber W. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–169. doi: 10.1093/bioinformatics/btu638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–930. doi: 10.1093/bioinformatics/btt656. [DOI] [PubMed] [Google Scholar]
  • 18.Love M, Anders S, Huber W. Differential analysis of count data–the Deseq2 package. Genome Biol. 2014;15:10–1186. doi: 10.1186/s13059-014-0550-8. [DOI] [Google Scholar]
  • 19.Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140. doi: 10.1093/bioinformatics/btp616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Arndt D, Grant JR, Marcu A, Sajed T, Pon A, et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res. 2016;44:W16–W21. doi: 10.1093/nar/gkw387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rosinski-Chupin I, Sauvage E, Fouet A, Poyart C, Glaser P. Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes. BMC Genomics. 2019;20:236. doi: 10.1186/s12864-019-5613-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Alam FM, Turner CE, Smith K, Wiles S, Sriskandan S. Inactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infection. PLoS One. 2013;8:e61655. doi: 10.1371/journal.pone.0061655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hildebrand A, Remmert M, Biegert A, Söding J. Fast and accurate automatic structure prediction with HHpred. Proteins. 2009;77:128–132. doi: 10.1002/prot.22499. [DOI] [PubMed] [Google Scholar]
  • 24.Wu S, Zhang Y. LOMETS: a local meta-threading-server for protein structure prediction. Nucleic Acids Res. 2007;35:3375–3382. doi: 10.1093/nar/gkm251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Potter SC, Luciani A, Eddy SR, Park Y, Lopez R, et al. HMMER web server: 2018 update. Nucleic Acids Res. 2018;46:W200–W204. doi: 10.1093/nar/gky448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Li Z, Jaroszewski L, Iyer M, Sedova M, Godzik A. FATCAT 2.0: towards a better understanding of the structural diversity of proteins. Nucleic Acids Res. 2020;48:W60–W64. doi: 10.1093/nar/gkaa443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Martí-Renom MA, Stuart AC, Fiser A, Sánchez R, Melo F, et al. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000;29:291–325. doi: 10.1146/annurev.biophys.29.1.291. [DOI] [PubMed] [Google Scholar]
  • 28.Melo F, Sali A. Fold assessment for comparative protein structure modeling. Protein Sci. 2007;16:2412–2426. doi: 10.1110/ps.072895107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics. 2011;27:343–350. doi: 10.1093/bioinformatics/btq662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293–315. doi: 10.1002/pro.3330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Calfee G, Danger JL, Jain I, Miller EW, Sarkar P, et al. Identification and characterization of serotype-specific variation in Group A Streptococcus pilus expression. Infect Immun. 2018;86:e00792-17. doi: 10.1128/IAI.00792-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zeng S, Liu Y, Wu M, Liu X, Shen X, et al. Identification and validation of reference genes for quantitative real-time PCR normalization and its applications in lycium. PLoS One. 2014;9:e97039. doi: 10.1371/journal.pone.0097039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hondorp ER, Hou SC, Hempstead AD, Hause LL, Beckett DM, et al. Characterization of the Group A Streptococcus Mga virulence regulator reveals a role for the C-terminal region in oligomerization and transcriptional activation. Mol Microbiol. 2012;83:953–967. doi: 10.1111/j.1365-2958.2012.07980.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hondorp ER, McIver KS. The Mga virulence regulon: infection where the grass is greener. Mol Microbiol. 2007;66:1056–1065. doi: 10.1111/j.1365-2958.2007.06006.x. [DOI] [PubMed] [Google Scholar]
  • 35.Tsvetanova B, Wilson AC, Bongiorni C, Chiang C, Hoch JA, et al. Opposing effects of histidine phosphorylation regulate the AtxA virulence transcription factor in Bacillus anthracis . Mol Microbiol. 2007;63:644–655. doi: 10.1111/j.1365-2958.2006.05543.x. [DOI] [PubMed] [Google Scholar]
  • 36.Pal D, Chakrabarti P. Non-hydrogen bond interactions involving the methionine sulfur atom. J Biomol Struct Dyn. 2001;19:115–128. doi: 10.1080/07391102.2001.10506725. [DOI] [PubMed] [Google Scholar]
  • 37.Podbielski A, Woischnik M, Leonard BA, Schmidt KH. Characterization of nra, a global negative regulator gene in group A streptococci. Mol Microbiol. 1999;31:1051–1064. doi: 10.1046/j.1365-2958.1999.01241.x. [DOI] [PubMed] [Google Scholar]
  • 38.Fogg GC, Caparon MG. Constitutive expression of fibronectin binding in Streptococcus pyogenes as a result of anaerobic activation of rofA. J Bacteriol. 1997;179:6172–6180. doi: 10.1128/jb.179.19.6172-6180.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gordon BRG, Li Y, Cote A, Weirauch MT, Ding P, et al. Structural basis for recognition of AT-rich DNA by unrelated xenogeneic silencing proteins. Proc Natl Acad Sci U S A. 2011;108:10690–10695. doi: 10.1073/pnas.1102544108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hadjifrangiskou M, Koehler TM. Intrinsic curvature associated with the coordinately regulated anthrax toxin gene promoters. Microbiology. 2008;154:2501–2512. doi: 10.1099/mic.0.2007/016162-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Tesorero RA, Yu N, Wright JO, Svencionis JP, Cheng Q, et al. Novel regulatory small RNAs in Streptococcus pyogenes . PLoS One. 2013;8:e64021. doi: 10.1371/journal.pone.0064021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Magalhães PP, Paulino TP, Thedei G, Jr Ciancaglini P. Kinetic characterization of P-type membrane ATPase from Streptococcus mutans . Comp Biochem Physiol B, Biochem Mol Biol. 2005;140:589–597. doi: 10.1016/j.cbpc.2004.12.007. [DOI] [PubMed] [Google Scholar]
  • 43.Vlaminckx BJM, Schuren FHJ, Montijn RC, Caspers MPM, Fluit AC, et al. Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray. Infect Immun. 2007;75:2603–2611. doi: 10.1128/IAI.01291-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Martín MG, Sender PD, Peirú S, de Mendoza D, Magni C. Acid-inducible transcription of the operon encoding the citrate lyase complex of Lactococcus lactis Biovar diacetylactis CRL264. J Bacteriol. 2004;186:5649–5660. doi: 10.1128/JB.186.17.5649-5660.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Srinivasan V, Morowitz HJ. Ancient genes in contemporary persistent microbial pathogens. Biol Bull. 2006;210:1–9. doi: 10.2307/4134531. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material 1
Supplementary material 2

Articles from Microbial Genomics are provided here courtesy of Microbiology Society

RESOURCES